Related Experiment Video
Updated: May 14, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Association of Serum P-Cresyl Sulfate Level with Peripheral Artery Disease in Kidney Transplantation Patients
Hsiao-Hui Yang1,2,3, Yen-Cheng Chen1,2, Chin-Hung Liu4,5
1Division of General Surgery, Department of Surgery, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan.
Insights
Higher levels of the uremic toxin p-cresyl sulfate (PCS) are linked to peripheral artery disease (PAD) in kidney transplant (KT) recipients. This suggests residual toxin burden impacts vascular health post-transplant.
Area of Science:
- Nephrology
- Vascular Biology
- Toxicology
Background:
- p-Cresyl sulfate (PCS) is implicated in endothelial dysfunction and vascular remodeling.
- Peripheral artery disease (PAD), indicated by a low ankle-brachial index (ABI), is a significant mortality risk in kidney transplant (KT) recipients.
Purpose of the Study:
- To investigate the association between serum PCS levels and PAD in KT recipients.
- To determine if PCS is an independent predictor of PAD in this population.
Main Methods:
- A cross-sectional study of 90 KT recipients.
- Serum PCS quantified by liquid chromatography-mass spectrometry.
- PAD defined as ABI < 0.9, measured via automated oscillometric device.
Main Results:
- 22.2% of KT recipients had PAD.
- PAD patients showed higher prevalence of diabetes and elevated serum PCS levels (p=0.001).
- Serum PCS levels were independently associated with PAD (OR 1.254, p<0.001) and inversely correlated with ABI.
Conclusions:
- Elevated serum PCS levels are independently associated with PAD in KT recipients.
- Residual uremic toxin burden may contribute to peripheral vascular disease post-KT.
- PCS may be a therapeutic target for preventing vascular complications in KT recipients.
Abstract:
Background: p-Cresyl sulfate (PCS) has been linked to vascular dysfunction through endothelial injury and vascular remodeling. Peripheral artery disease (PAD), identified by a low ankle-brachial index (ABI), is associated with increased mortality in kidney transplant (KT) recipients. This study investigated the association between serum PCS levels and PAD (as defined by ABI) in KT recipients. Methods: This cross-sectional, single-center study included 90 KT recipients. Serum total PCS levels were quantified using liquid chromatography-mass spectrometry. ABI was measured using an automated oscillometric device, and PAD was defined as ABI < 0.9. Results: Among the 90 KT recipients, 20 (22.2%) met the ABI for PAD. Patients with ABI-defined PAD had a significantly higher prevalence of diabetes mellitus (p = 0.036) and serum PCS levels (p = 0.001). Multivariate logistic regression analysis adjusting for potential confounders revealed that serum PCS levels remained independently associated with PAD (odds ratio 1.254, 95% confidence interval 1.108-1.419; p < 0.001). PCS levels were inversely correlated with both left (r = -0.339, p = 0.001) and right (r = -0.357, p < 0.001) ABIs. The association remained consistent in penalized regression models. Conclusions: Higher serum PCS levels were independently associated with ABI-defined PAD in KT recipients. The findings indicate that residual uremic toxin burden may contribute to peripheral vascular disease despite the restoration of renal function following transplantation.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease III: Interprofessional Care
